$
0. 27
-0.01
-3.5714%
$
27.6M Market Cap
- P/E Ratio
- Div Yield
631,200 Volume
-0.22 Eps
$ 0.28
Previous Close 
Want to track IGC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
IGC Pharma Inc. (IGC) Statistics
Valuation metrics
Market Cap 27.6M
Enterprise value 28.23M
Trailing P/E (ttm) -3.99
Forward P/E -
PEG ratio -0.2
Price/Sales (ttm) 23.2
Price/Book (mrq) 4.27
Enterprise Value/Revenue 23.81
Enterprise Value/EBITDA -4.58
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 629.3K
Average volume (90 days) 1.38M
Price summary
52-Week low 0.24
52-Week high 0.5
Beta -
50-Day moving average 0.3
200-Day moving average 0.29
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 19 Apr 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.52%
Operating margin -8.6%
Operational effectiveness
Return on assets -0.71%
Return on equity -0.95%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 0.4%
Book value per share (mrq) 0.06
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
